NCT00003170 arm group 6b6693d75a22b95d1b11635b05ec7315 [clinicaltrials_resource:NCT00003170/arm-group/6b6693d75a22b95d1b11635b05ec7315]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003170 arm group 6b6693d75a22b95d1b11635b05ec7315 [clinicaltrials_resource:NCT00003170/arm-group/6b6693d75a22b95d1b11635b05ec7315]
Bio2RDF identifier
NCT00003170/arm-group/6b6693d75a22b95d1b11635b05ec7315
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 6693d75a22b95d1b11635b05ec7315
description [clinicaltrials_vocabulary:description]
Beginning the first or second ...... 24 months after radiotherapy.
identifier
clinicaltrials_resource:NCT00003170/arm-group/6b6693d75a22b95d1b11635b05ec7315
title
NCT00003170 arm group 6b6693d75a22b95d1b11635b05ec7315
@en
type
label
NCT00003170 arm group 6b6693d7 ...... 693d75a22b95d1b11635b05ec7315]
@en